Skip to search formSkip to main contentSkip to account menu

mebeverine

Known as: 4-(ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) veratrate, duspatalin, spasmotalin 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

AnticonvulsantsParasympatholyticsPhenethylamines
Mebeverine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Treatment of irritable bowel syndrome using a selected herbal combination of Iraqi folk medicines.
Highly Cited
2011
Highly Cited
2011
Improved removal of estrogenic and pharmaceutical compounds in sewage effluent by full scale granular activated carbon: impact on receiving river water.
Review
2010
Review
2010
A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.
We evaluated the efficacy and tolerability of mebeverine, a musculotropic antispasmodic agent, in irritable bowel syndrome (IBS… 
Review
2010
Review
2010
Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy…
BackgroundIBS affects 10-22% of the UK population. Abdominal pain, bloating and altered bowel habit affect quality of life… 
Highly Cited
2005
Highly Cited
2005
Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial
Abstract Objective To assess the efficacy of cognitive behaviour therapy delivered in primary care for treating irritable bowel… 
Highly Cited
2003
Highly Cited
2003
On-line micellar electrokinetic chromatography-mass spectrometry: feasibility of direct introduction of non-volatile buffer and surfactant into the electrospray interface.
Highly Cited
1999
Highly Cited
1999
Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients
: Irritable bowel syndrome is one of the most common gastrointestinal disorders, yet no therapy convincingly controls the… 
1994
1994
Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome
Aim: To assess the efficacy of smooth muscle relaxants in the treatment of patients with irritable bowel syndrome, a meta… 
Highly Cited
1986
Highly Cited
1986
Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.
There is no generally accepted treatment in the irritable bowel syndrome (IBS), probably because of a lack of convincing… 
Highly Cited
1965
Highly Cited
1965
Physiological and clinical assessment of the effect of the musculotropic agent mebeverine on the human colon.
We are indebted to Professor R. C. Wofinden and Dr. J. F. Skone, of the Department of Public Health, for their help in arranging… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)